¿Los pediatras detectan las reacciones adversas a medicamentos aunque no las reporten?

Uppsala Monitoring Centre. Glossary of terms used in Pharmacovigilance. Uppsala, Suecia: WHO; 2015 [consultado 13 enero 2015]. Disponible en: http://www.who-umc.org/graphics/28401.pdf. Khan, 2013, Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay—a systematic review, Eur J Clin Pharmacol., 69, 1985, 10.1007/s00228-013-1563-z Smyth, 2012, Adverse drug reactions in children—a systematic review, PLoS One., 7, e24061, 10.1371/journal.pone.0024061 Telechea, 2012, Adverse drug reactions in a paediatric intensive care unit, Farm Hosp., 36, 403, 10.1016/j.farma.2011.08.007 Gallagher, 2012, Adverse drug reactions causing admission to a paediatric hospital, PLoS One., 7, e50127, 10.1371/journal.pone.0050127 Finkelstein, 2011, Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children, Pediatrics., 128, 723, 10.1542/peds.2010-3322 Oshikoya, 2011, Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria, Sao Paulo Med J., 129, 153, 10.1590/S1516-31802011000300006 Thürmann, 2001, Methods and systems to detect adverse drug reactions in hospitals, Drug Saf., 24, 961, 10.2165/00002018-200124130-00003 Star, 2011, Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase, Drug Saf., 34, 415, 10.2165/11587540-000000000-00000 Hazell, 2006, Under-reporting of adverse drug reactions: a systematic review, Drug Saf., 29, 385, 10.2165/00002018-200629050-00003 Lopez-Gonzalez, 2009, Determinants of under-reporting of adverse drug reactions: a systematic review, Drug Saf., 32, 19, 10.2165/00002018-200932010-00002 Neubert, 2004, The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients, Drug Saf., 27, 1059, 10.2165/00002018-200427130-00006 Oehme, 2012, Adverse drug reactions in hospitalised children in Germany are decreasing: results of a nine year cohort-based comparison, PLoS One., 7, e44349, 10.1371/journal.pone.0044349 Haffner, 2005, Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values, Drug Saf., 28, 453, 10.2165/00002018-200528050-00008 Diario Oficial de la Federación. Norma Oficial Mexicana NOM-220-SSA1-2012, Instalación y operación de la farmacovigilancia. Secretaría de Salud. Publicada en el Diario Oficial de la Federación el 07/01/2013. Jasso-Gutiérrez, 2009, Diseño e implantación de un programa electrónico de farmacovigilancia con captura en línea en el Hospital Infantil de México Federico Gómez, Bol Med Hosp Infant Mex., 66, 51 Hospital Infantil de México Federico Gómez. Anuario estadístico de servicios médicos 2008. México, D.F.: Secretaría de Salud; 2008 [consultado 13 enero 2015]. Disponible en: http://www.himfg.edu.mx/descargas/documentos/planeacion/AnuariosEst/anuarioHIMFG2008.pdf. Hospital Infantil de México Federico Gómez. Anuario estadístico de servicios médicos 2009. México, D.F.: Secretaría de Salud; 2009 [consultado 13 enero 2015]. Disponible en: http://www.himfg.edu.mx/descargas/documentos/planeacion/AnuariosEst/AnuarioHIMFG2009.pdf. Truven Health Analytics. Micromedex 2.0. [consultado 13 enero 2015]. Disponible en: http://www.micromedex.com/. European Medicines Agency. ICH Topic E 11. Clinical Investigation of Medicinal Products in the Paediatric Population. Londres: EMEA; 2001 [consultado 13 enero 2015]. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002926.pdf. World Health Organization. WHO AnthroPlus software. Ginebra: WHO; 2007 [consultado 13 enero 2015]. Disponible en: http://www.who.int/growthref/tools/en/. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Ginebra: WHO; 2010 [consultado 13 enero 2015]. Disponible en: http://apps.who.int/classifications/icd10/browse/2010/en. Phansalkar, 2007, Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review, Am J Health Syst Pharm., 64, 842, 10.2146/ajhp060335 Park, 2013, Evaluation of adverse drug reactions in medical intensive care units, Eur J Clin Pharmacol., 69, 119, 10.1007/s00228-012-1318-2 Becerril-Ángeles, 2011, [Survey of adverse reactions to drugs in hospitalized patients], Rev Alerg Mex., 58, 179 Weiss, 2002, Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection, Pediatrics., 110, 254, 10.1542/peds.110.2.254 Forster, 2012, A systematic review to evaluate the accuracy of electronic adverse drug event detection, J Am Med Inform Assoc., 19, 31, 10.1136/amiajnl-2011-000454 Neubert, 2006, Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients?, Eur J Clin Pharmacol., 62, 959, 10.1007/s00228-006-0197-9 Calvo, 2014, EU's new pharmacovigilance legislation: considerations for biosimilars, Drug Saf., 37, 9, 10.1007/s40264-013-0121-z